Anaplastic Oligodendroglioma Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
- High Grade Glioma
- +3 more
- Regadenoson 0.05mg
- +6 more
- Birmingham, Alabama
- +2 more
2022-04-07
Apr 7, 2022S
Recruiting
- Anaplastic Astrocytoma
- +55 more
- Gemcitabine
- +4 more
- Memphis, TennesseeSt. Jude Children's Research Hospital
2022-04-01
Apr 1, 2022O
Completed
- Anaplastic Oligoastrocytoma
- +3 more
- Carboplatin
- +7 more
- Minneapolis, Minnesota
- +1 more
2022-03-11
Mar 11, 2022N
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG
Active, not recruiting
- Diffuse Astrocytoma
- +21 more
- dabrafenib
- +2 more
- Orange, California
- +56 more
2022-03-02
Mar 2, 2022P
Active, not recruiting
- Medulloblastoma
- +7 more
- SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
- +2 more
- Buffalo, New YorkRoswell Park Comprehensive Cancer Center
2022-02-15
Feb 15, 2022C
Recruiting
- Central Nervous System Neoplasms
- +22 more
- Bethesda, MarylandNational Institutes of Health
2022-03-01
Mar 1, 2022P
Recruiting
- Glioblastoma Multiforme
- +5 more
- Los Angeles, California
- +12 more
2022-01-27
Jan 27, 2022N
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
- Duarte, California
- +1 more
2022-01-10
Jan 10, 2022M
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
- Houston, TexasM D Anderson Cancer Center
2021-11-17
Nov 17, 2021N
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
- Los Angeles, California
- +11 more
2021-10-20
Oct 20, 2021S
Recruiting
- Medulloblastoma
- +7 more
- Saint Petersburg, Florida
- +1 more
2021-09-17
Sep 17, 2021I
Active, not recruiting
- Malignant Glioma
- +10 more
- Polio/Rhinovirus Recombinant (PVSRIPO)
- Durham, North CarolinaDuke University Medical Center
2021-07-12
Jul 12, 2021D
Recruiting
- Astrocytoma
- +8 more
- Boston, Massachusetts
- +3 more
2021-05-30
May 30, 2021N
Recruiting
- Diffuse Astrocytoma
- +22 more
- Phoenix, Arizona
- +16 more
2021-04-16
Apr 16, 2021O
Recruiting
- Grade II Glioma
- +7 more
- Microdevice
- Boston, MassachusettsBrigham and Women's Hospital
2021-02-22
Feb 22, 2021A
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
- New York, New York
- +1 more
2021-01-06
Jan 6, 2021U
Withdrawn
- Anaplastic Oligodendroglioma
- +2 more
- Wear novoTTF-200A
- Quality-of-Life Assessment
- Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
2020-12-08
Dec 8, 2020E
Active, not recruiting
- Glioblastoma
- +2 more
- RRx-001 dose escalation with TMZ + RT
- +3 more
- San Francisco, California
- +2 more
2020-07-21
Jul 21, 2020M
Completed
- Anaplastic Astrocytoma
- +3 more
- Carcinoembryonic Antigen-Expressing Measles Virus
- +2 more
- Rochester, MinnesotaMayo Clinic
2019-12-31
Dec 31, 2019N
Completed
- Glioblastoma Multiforme
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2019-12-11
Dec 11, 2019W
Withdrawn
- Glioblastoma Multiforme
- +2 more
- MRS Spectroscopy
- New York, New YorkWeill Cornell Medical College Department of Neurosurgery
2019-05-30
May 30, 2019N
Terminated
- Low Grade Glioma
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2018-07-03
Jul 3, 2018T
Completed
- Glioblastoma
- +3 more
- Toca 511 vector
- Toca FC
- Duarte, California
- +9 more
2018-05-16
May 16, 2018T
Completed
- Glioblastoma Multiforme
- +3 more
- Toca 511 vector
- Toca FC
- Los Angeles, California
- +7 more
2018-05-16
May 16, 2018T
Completed
- Glioblastoma Multiforme
- +3 more
- Toca 511
- Toca FC
- Irvine, California
- +5 more
2018-05-16
May 16, 2018